A polyclonal antibody was raised against a Toxoplasma gondii 14-3-3^gluthatione S-transferase fusion protein obtained by cloning a 14-3-3 cDNA sequence determined from the T. gondii database. This antibody specifically recognized T. gondii 14-3-3 without any crossreaction with mammalian proteins. Immunofluorescence microscopy studies of the tachyzoites or the T. gondii-infected cells suggested cytosolic and membranous localizations of 14-3-3 protein. Different subcellular fractions were prepared for electrophoresis analysis and immunodetection. 14-3-3 proteins were found in the cytosol, the membrane fraction and Triton X-100-resistant membranes. Two 14-3-3 isoforms were detected. The major one was mainly cytoplasmic and to a lesser extent membrane-associated, whereas the minor isoform was associated with the detergent-resistant lipid rafts. ß
Introduction
14-3-3 proteins constitute a family of highly conserved proteins, present in all eukaryotic organisms [1] . Mammalian cells have been shown to contain ¢ve to eight di¡erent 14-3-3 genes encoding di¡erent isoforms designated by Greek letters [2, 3] . In the case of higher plants, 10 isoforms have been identi¢ed in Arabidopsis thaliana [4] , while in the case of yeasts, two isoforms have been described for Saccharomyces cerevisiae and Schizosaccharomyces pombe [5^7]. One isoform was identi¢ed in Candida albicans [8] . Most 14-3-3 isoforms are located in the cytoplasm, although some are associated with membranes, as described for the green alga Chlamydomonas reinhardtii and for rat brain [9^11] . Although the exact function of 14-3-3 proteins has not been completely elucidated, they are known to stimulate protein^protein interactions by acting as molecular sca¡olds or chaperones, and are involved in the regulation of the subcellular localization of proteins, and in the activation or inhibition of enzymes [12] . In mammals, 14-3-3 proteins have been shown to be involved in the regulation of mitosis [13, 14] and in signal transduction via the mitogen-activated protein kinase cascade [15, 16] .
Concerning parasites, the number of 14-3-3 isoforms, their subcellular distribution and their functions are not so well established. We only know that their mRNA is expressed in the protozoon Plasmodium falciparum [17] and 14-3-3 proteins are present in helminths such as Echinococcus multilocularis and Echinococcus granulosus [18] or Schistosoma mansoni. In these latter parasites, they have been reported to be involved in parasite growth and survival [19] .
Toxoplasma gondii, another protozoon, is an intracellular parasite known to cause severe congenital infection in humans and animals [20] . As a sporozoon, its sexual reproduction occurs in the intestine of its de¢nitive hosts, the cat, while its asexual multiplication involves nucleated cells of various hosts, in particular humans [20] . 14-3-3 protein has been shown to be present in T. gondii during the feline enteroepithelial stage and has not been detected in the tachyzoite, the asexual parasite form [21] . Tachyzoites are able to invade cells and multiply at a high rate in a particular intracellular organite, the parasitophorous vacuole [22, 23] . Since previous studies in mammals have involved 14-3-3 proteins in cell multiplication, we chose to reinvestigate the presence of 14-3-3 protein during the asexual stage of the parasite.
The present study reports the presence of a 14-3-3 protein homolog in a T. gondii RH strain, a virulent strain with a high tachyzoite multiplication rate. The generation of fusion proteins from the tachyzoite mRNA enabled the production of a rabbit polyclonal anti-T. gondii 14-3-3 antibody. This antibody was used to localize 14-3-3 protein in the tachyzoite. This study is the ¢rst report of the presence of two di¡erent 14-3-3 isoforms in tachyzoites. One is mainly cytosolic and membrane-associated, while the other is only present in the lipid rafts which are Triton X-100-resistant membrane microdomains.
Materials and methods

Parasite and cell lines
The virulent RH strain of T. gondii is maintained by intraperitoneal passages in OF1 female mice. The tachyzoites were collected by peritoneal washing with physiological serum [24] . HeLa cells were grown in Dulbecco's modi¢ed Eagle's medium. The THP1 (human monocyte) cell line and THP1 cells infected by the RH strain were grown in RPMI Glutamax medium (Invitrogen, France). Both media were supplemented with 5000 U ml 31 penicillin, 5000 Wg ml 31 streptomycin and 10% fetal calf serum (Invitrogen, France). Cultures were performed in a humidi¢ed 5% CO 2 incubator at 37 ‡C.
Reagents
The protease inhibitor cocktail (leupeptin, aprotinin and pepstatin A) was purchased from Sigma (France). SAG1 (IgG2A) monoclonal antibody (clone P1E1E7) was obtained from Bio-Me ¤rieux (France) and diluted to 1:1000 before use. GRA1 monoclonal antibody was kindly provided by C. Mercier (CNRS, Grenoble, France) and diluted to 1:1000 and 1:20 000 for immuno£uorescence and Western blot, respectively. The secondary antibodies were anti-rabbit Alexa-conjugated antibody used at 1:400 dilution (Interchim, France), and goat anti-mouse phycoerythrin-conjugated antibody diluted to 1:200 (Zymed, USA). All antibodies were diluted in phosphate-bu¡ered saline (PBS) and 1% bovine serum albumin (BSA) for immuno£uorescence staining.
2.3. Production of T. gondii 14-3-3 recombinant protein Koyama's T. gondii Express Sequence Tag database was searched to obtain the open reading frame sequence of 14-3-3 protein that was used to design the following primer pair: (i) sense 5P-ACGGAATTCACGATGGCGGAG-GAAATC-3P, creating an EcoRI site near the start codon, and (ii) antisense 5P-ACGTCGACTTACTGATCAGCT-TGTTCTG-3P, including a SalI site near the stop codon [25] . These primers were used to amplify the tachyzoite 14-3-3 cDNA from RNA puri¢ed with Trizol reagents (Invitrogen, France). The 14-3-3 cDNA was cloned into the EcoRI and SalI sites of the pBluescript KS þ vector (Stratagene, USA). The 14-3-3 pBluescript clone was digested and subcloned into the pGEX-4T-2 expression vector (Amersham Pharmacia Biotech, France). The resulting gluthatione S-transferase (GST) fusion protein was expressed in Escherichia coli DH5K (Invitrogen, France) after induction with 0.1 mM isopropyl-L-D-thiogalactopyranoside for 4^6 h at 37 ‡C. The protein was then solubilized and puri¢ed with glutathione S-Sepharose 4B beads (Amersham Pharmacia Biotech, France).
Production and puri¢cation of anti-recombinant
T. gondii 14-3-3 antibody
Antiserum production was carried out by intradermal injections of GST fusion T. gondii 14-3-3 protein to rabbits (Covalab, France). Anti-T. gondii polyclonal 14-3-3 antibodies were puri¢ed on immobilized protein G column (Pierce, USA). After anti-GST antibody depletion by incubation with GST protein and gluthatione S-Sepharose 4B beads, anti-T. gondii polyclonal 14-3-3 antibodies were diluted to 1:250 for immuno£uorescence staining and to 1:2000 for Western blot analysis. For antibody characterization, 1.5U10 6 HeLa cells were transfected using the lipofectamine method (Invitrogen, France) with 5 Wg of T. gondii 14-3-3 homologous cDNA subcloned into mammalian vectors PciNeo (Promega, France) and PcDNA (Invitrogen, France).
SDS^PAGE and immunoblot analysis
Proteins were separated by sodium dodecyl sulfatep olyacrylamide gel electrophoresis (SDS^PAGE) electrophoresis using a 15% gel, then transferred to a polyvinylidene di£uoride (PVDF) membrane (Immobilon, Millipore) [26] . Immunodetection was performed using the speci¢c polyclonal or monoclonal antibodies (see Sections 2.2 and 2.4). Detection was performed by peroxidase conjugation using the anti-species secondary antibody (Dako, France) diluted to 1:2000 for anti-rabbit antibody and 1:1000 for anti-mouse antibody. The antigens were detected using enhanced chemiluminescence detection reagents (Amersham, France). The densitometric analysis of the antigens was performed by densitometric scanning with Kodak Digital science 1D Image Analysis software.
Immuno£uorescence microscopy
Tachyzoites obtained from ascites were washed three times in PBS, ¢xed with PBS/2% paraformaldehyde for 10 min, then washed extensively with PBS. The puri¢ed polyclonal anti-T. gondii 14-3-3 antibody and monoclonal antibodies against SAG1 or GRA1 were applied for 1 h at 37 ‡C. After washing three times with PBS, the parasites were incubated for 45 min at 37 ‡C with mixed secondary antibodies. T. gondii-infected THP1 cells were ¢xed like parasites and permeabilized for 30 min in PBS containing 1% BSA and 0.25% Triton X-100. Then antibodies were applied as described above. The free parasites and T. gondii-infected THP1 cells were both deposited on slides, then counter-stained with bisbenzimide 3358 used at 0.1 Wg ml 31 . After drying, the slides were mounted in Vectashield (Vector Laboratories, Germany) and were observed under a £uorescence microscope (Axioplan Zeiss, France).
Subcellular fractionation
10
9 tachyzoites were extracted in bu¡er I (25 mM TrisĤ Cl, pH 7.5, 1 mM EDTA, 1 mM EGTA, protease inhibitors and 1 mM phenylmethylsulfonyl £uoride) by serial cycles of freezing (3180 ‡C) and thawing (37 ‡C) . After centrifugation at 600Ug for 5 min, the supernatants (LSS) were centrifuged at 150 000Ug for 30 min to separate the membranous pellet (HSP), further suspended in bu¡er I, from supernatant (HSS).
Preparation of Triton X-100-resistant membrane
complexes by gradient centrifugation 2U10 9 tachyzoites were incubated at 4 ‡C in 2 ml of bu¡er II (10 mM Tris^HCl, pH 7.5, 1 mM MgCl 2 , 150 mM NaCl) containing protease inhibitors, 60% sucrose and 1% Triton X-100. After 1 h incubation, the extract was overlaid with 4 ml of 50%, 40%, 35%, 30%, 25% sucrose and 3.5 ml of 20%, 15%, 10%, 5% sucrose in bu¡er II. After ultracentrifugation at 121 000Ug for 24 h at 4 ‡C, 1-ml aliquots were collected from the bottom to the top of the gradient tube. Proteins were titrated with the D c Protein assay system (Bio-Rad, France). The sucrose concentration was determined with a RRA refractometer (PZO, Poland).
Results
Characterization of recombinant T. gondii 14-3-3 antibodies
Anti-T. gondii 14-3-3 homologous antibodies depleted of anti-GST antibodies showed, after SDS electrophoresis and Western blot, no reaction with GST (Fig. 1A, lane 1) and a positive reaction with GST-T. gondii 14-3-3 homologous fusion protein which migrated at 61 kDa (Fig. 1A,  lane 2) . These antibodies recognized only one band migrating at 36 kDa in tachyzoite cytosol extracts (Fig.  1A, lane 3) , indicating the presence of a 14-3-3 protein homolog in T. gondii tachyzoites. The di¡erences in apparent molecular mass observed between the protein detected in Fig. 1A , lane 2 and that in lane 3 are due to the presence of the GST sequence. When lysates from HeLa cells transfected with di¡erent vectors were used, only cells containing the 14-3-3 homologous cDNA vector reacted positively at 36 kDa for PciNeo and 40 kDa for PcDNA (Fig. 1B) . The di¡erence in molecular mass is related to the presence of a histidine tag in the PcDNA vector. 
Localization of T. gondii 14-3-3 protein homolog by immuno£uorescence analysis
The 14-3-3 protein homolog was localized in free T. gondii tachyzoites by immuno£uorescence analysis using the polyclonal anti-T. gondii 14-3-3 homologous antibody and antibodies speci¢c for either cytosolic (GRA1) [27] or membrane glycosylphosphatidylinositol (GPI)-anchored (SAG1) proteins [28] . When both anti-T. gondii 14-3-3 and SAG1 antibodies were used simultaneously on unpermeabilized tachyzoites, the SAG1 labeling was e¡ectively found in the pellicle of the tachyzoites whereas 14-3-3 antibody produced a more di¡use labeling with spots in the cytosol. Moreover, the presence of yellow spots in the overlay view ( Fig. 2A) suggests a partial colocalization of 14-3-3 protein with SAG1 in the T. gondii membrane.
When both anti-T. gondii 14-3-3 and GRA1 antibodies were used simultaneously on unpermeabilized tachyzoites (Fig. 2B) , the 14-3-3 labeling was similar to that observed in Fig. 2A , as expected. The very low labeling obtained with GRA1 antibody (Fig. 2B) suggests a weak di¡usion of the antibody into the parasites. This absence of labeling con¢rms the cytosolic localization of the protein. The overlay view of GRA1 and 14-3-3 (Fig. 2B) showed no well-de¢ned yellow spots, indicating the absence of protein overlapping.
Tachyzoites were then treated with Triton X-100 before antibody labeling. Under these conditions, the binding of SAG1 disappeared, suggesting either a membrane solubi- Fig. 2 . Immuno£uorescence of paraformaldehyde-¢xed, double-stained T. gondii parasites or THP1 cells infected with T. gondii. Antibodies used for double staining were : line A, anti-14-3-3 antibody and monoclonal SAG1 antibody; line B, anti-GRA1 monoclonal antibody and anti-14-3-3 antibody ; line C, parasites permeabilized with Triton X-100 were stained with monoclonal anti-GRA1 antibody and anti-14-3-3 antibody; line D, infected cells were ¢xed and permeabilized before staining with mixed anti-SAG1 and anti-14-3-3 antibodies. The stains were revealed with anti-species secondary antibodies (see Section 2.2). Counter-staining was performed with bisbenzimide 3358. The images were acquired with an Axioplan microscope (Zeiss, France) and the overlapping analysis was performed with Soft imaging system software (Eloise, France) (bar = 5 Wm).
lization or the absence of epitope recognition by the speci¢c antibody, while the 14-3-3 labeling persisted (data not shown).
When both anti-T. gondii 14-3-3 and GRA1 antibodies were used simultaneously on permeabilized tachyzoites (Fig. 2C) , both views showed intense labeling with red or green spots, re£ecting e¡ective antibody penetration. The presence of intense yellow labeling in the overlay view indicates a colocalization of both proteins in the cytosol of free tachyzoites.
To see if intracellular tachyzoites as well as free tachyzoites can induce 14-3-3 production, RH strain-infected THP1 cells were studied. Without permeabilization, proteins could not be detected in tachyzoites with either 14-3-3 or SAG1 antibodies. Cells were then permeabilized to allow the penetration of the antibodies. This enabled tachyzoite menbrane labeling by both 14-3-3 and SAG1 antibodies (Fig. 2D) , showing the integrity of the parasite membrane. Furthermore, colocalization of the two proteins in the tachyzoite membrane was observed in the overlay view (Fig. 2D ).
Subcellular distribution of 14-3-3 proteins
The di¡erent subcellular fractions obtained from freshly prepared tachyzoites were analyzed by SDS^PAGE and Western blot analysis using the anti-14-3-3 antibody. 14-3-3 protein was detected in the post-nuclear fraction (Fig. 3, lane LSS) . After high-speed centrifugation of the LSS, the protein was concentrated in the soluble cytosolic fraction (Fig. 3, lane HSS) but was also present at a lower level in the membrane fraction (Fig. 3, lane HSP) . In agreement with microscopic data, these results show the presence of 14-3-3 protein in the membrane and in the cytosol of T. gondii.
14-3-3 subcellular distribution was con¢rmed by using the above-mentioned reference proteins as controls. (i) SAG1, detected in trace amounts in the post-nuclear fraction (Fig. 3, lane LSS) , was absent from the soluble cytosolic fraction (lane HSS), while it was concentrated in the membrane fraction (lane HSP). (ii) GRA1 was detected at the same level in LSS and HSS, while it was absent from HSP (Fig. 3) . Results obtained with reference proteins indicate a good fractionation of cytosol and membranes of T. gondii tachyzoites in our conditions.
Detection of 14-3-3 protein in T. gondii detergent-resistant membranes
The plasma membranes of many cell types contain specialized membrane microdomains, the lipid rafts, which are resistant to non-ionic detergents (such as Triton X- 3 . Western blot analysis of subcellular fractions of T. gondii. Tachyzoites were lysed by serial freezing and thawing in lysis bu¡er. The homogenates were centrifuged at low speed (600Ug). The post-nuclear fraction (LSS) was subjected to high-speed centrifugation to separate the supernatant (HSS) and the pellet (HSP). Aliquots of the di¡erent subcellular fractions (1 Wg protein per lane) were separated by 15% SDS^PAGE, then transferred to PVDF membrane before immunostaining with either polyclonal anti-14-3-3 antibody raised against the GST/ 14-3-3 fusion protein depleted of anti-GST antibody, or monoclonal anti-SAG1 and anti-GRA1 antibodies. 100) used at 4 ‡C. These detergent-resistant membranes (DRM) are enriched in GPI-anchored proteins [29, 30] .
To get more information about the localization of 14-3-3 protein in the T. gondii membrane, Triton X-100-resistant membranes were prepared from the tachyzoites. After ultracentrifugation, a weak peak of proteins (Fig. 4 , open circles) was observed in the gradient between 26 and 24% sucrose. To check whether this peak corresponded to DRM, the presence of SAG1, a GPI-anchored protein of T. gondii, was tested by immunodetection, revealing that SAG1 (Fig. 4A , dark circles) was actually associated with the peak of proteins. 14-3-3 distribution along the gradient was compared to that of the soluble protein GRA1 of T. gondii (Fig. 4B ). High levels of both proteins were detected at the bottom of the gradient tube, then decreased progressively until fraction 13, while only 14-3-3 was present as an intense band in the DRM peak (fraction 21). The molecular mass of the DRM-associated 14-3-3 protein (14-3-3 DRM ) was found to be slightly lower than that of the non-DRM 14-3-3 protein, suggesting the presence of two di¡erent forms in the tachyzoites. The amount of 14-3-3 protein present in the di¡erent subcellular fractions was estimated by measuring spot intensities after immunoblotting (Fig. 5) . The 14-3-3 DRM isoform represented less than 4% of the total membrane-associated 14-3-3 protein.
Discussion
In this work, we have shown that 14-3-3 protein is present in the asexual form of T. gondii, corresponding to the tachyzoite stages, the form of the parasite that is virulent in humans. Moreover, 14-3-3 was detected when tachyzoites were free and when they were infecting human THP1 cells. 14-3-3 protein was previously described as absent in RH strain tachyzoites [21] . This apparent contradiction between our results and those of Koyama et al. [21] might be due to di¡erences in the immunoa⁄nities of the antibodies used in each study.
Detection by immuno£uorescence microscopy showed that 14-3-3 protein is cytosolic since it could be detected in permeabilized parasites, along with the cytosolic GRA1 protein. 14-3-3 protein is also membrane-associated, as evidenced by its colocalization with SAG1 protein in non-permeabilized parasites. These two localizations were con¢rmed by immunodetection of 14-3-3 in the subcellular fractions. Under these conditions, the amount of 14-3-3 protein present in the cytosol and in the membranes could be roughly estimated. 14-3-3 protein is mainly cytosolic, but it is also found with the membrane-associated protein fraction. Both cytosolic and membrane-associated 14-3-3 proteins have the same apparent molecular mass. This is the ¢rst report of a membranous form of 14-3-3 protein in the tachyzoites of T. gondii. In the cases of rat brain and C. reinhardtii subcellular localization of 14-3-3 proteins, most 14-3-3 isoforms were cytosolic, and only a small proportion was selectively membrane-associated [9, 10] , which is in agreement with the results presented here.
The localization of 14-3-3 protein in the parasite membrane was assessed using DRM prepared from T. gondii. A large proportion of the 14-3-3 protein was solubilized by Triton X-100. However, a new minor isoform (14-3-3 DRM ) with a lower apparent molecular mass was Tritonresistant at 4 ‡C and was found to be speci¢cally bound to DRM. This apparent low level of the 14-3-3 DRM isoform could be due to its lower a⁄nity for the antibodies. This DRM selectivity was not previously described in studies on 14-3-3 subcellular localization [20, 32] . The 14-3-3 DRM isoform could be produced either (i) by other genes encoding di¡erent protein isoforms, as described for another parasite, Schistosoma mansoni [19] , or (ii) by post-translational modi¢cations of the protein as is the case for the L/K and j/N isoforms in mammals [31] . Analyzing the di¡erences between the two 14-3-3 isoforms of T. gondii would be interesting, although it would require a signi¢cant quantity of isoform. Until now, the low amount of 14-3-3 DRM associated with DRM has not made this structural analysis possible. However, di¡erent 14-3-3 isoforms were found in all eukaryotes. These forms may be associated with di¡erent functions, as shown for mammals; for example, 14-3-3j has been found to interact with the wee1 kinase, which plays a key role in cell cycle progression by inactivating cyclin-dependent kinases [32] , whereas 14-3-3c is induced by p53 in response to Q-irradiation and other DNA-damaging agents [13] .
In the case of parasites, 14-3-3 proteins have been reported to play a role for the helminth, as they are implicated in the tumor-like growth process of E. multilocularis metacestode [18] . In S. mansoni, 14-3-3 proteins have a role in host immunity, parasite development and survival [34] . A physical association with Raf protein, a signal transduction protein localized in rafts [33^35], was also reported for S. mansoni [19] . Rafts are postulated to function as platforms supporting numerous cellular events [36, 37] . Their roles are presently unknown for protozoa. The presence of a DRM-speci¢c 14-3-3 isoform in T. gondii could be correlated with the involvement of the lipid rafts in signal transduction. So, studying the di¡erent 14-3-3 proteins of T. gondii tachyzoites could be important to unravel their roles in parasite growth and its survival in the host.
